Skip to main content
. 2013 Aug 16;4(5):477–483. doi: 10.1007/s12975-013-0281-2

Table 1.

Clinical trials for stroke immunotherapy

Target Condition Intervention Phase Description
E-selectin Ischemic stroke E-selectin nasal spray II Terminated (NCT00012454)
E-selectin Ischemic stroke Recombinant human E-selectin I Not recruited (NCT00069069)
Nogo-A Acute spinal cord injury ATI355 (anti-Nogo-A) I Completed (NCT00406016)
ICAM-1 Acute stroke Enlimomab (anti-ICAM-1) III Completed (Enlimomab Acute Stroke Trial)